Atrash, S.; Mammadzadeh, A.; Peng, F.; Alkharabsheh, O.; Afrough, A.; Cui, W.; Mahmoudjafari, Z.; Abdallah, A.-O.; Hashmi, H.
Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy. Cancers 2023, 15, 2891.
https://doi.org/10.3390/cancers15112891
AMA Style
Atrash S, Mammadzadeh A, Peng F, Alkharabsheh O, Afrough A, Cui W, Mahmoudjafari Z, Abdallah A-O, Hashmi H.
Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy. Cancers. 2023; 15(11):2891.
https://doi.org/10.3390/cancers15112891
Chicago/Turabian Style
Atrash, Shebli, Aytaj Mammadzadeh, Fulei Peng, Omar Alkharabsheh, Aimaz Afrough, Wei Cui, Zahra Mahmoudjafari, Al-Ola Abdallah, and Hamza Hashmi.
2023. "Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy" Cancers 15, no. 11: 2891.
https://doi.org/10.3390/cancers15112891
APA Style
Atrash, S., Mammadzadeh, A., Peng, F., Alkharabsheh, O., Afrough, A., Cui, W., Mahmoudjafari, Z., Abdallah, A. -O., & Hashmi, H.
(2023). Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy. Cancers, 15(11), 2891.
https://doi.org/10.3390/cancers15112891